PDK2 antisense RNA 1 (PDK2-AS1)

PDK2 antisense RNA 1 (PDK2-AS1) is an antisense long non-coding RNA (lncRNA) transcribed from the DNA strand opposite the PDK2 gene locus. Like other natural antisense transcripts (NATs), it may regulate the expression of its sense counterpart (PDK2) via mechanisms such as transcriptional interference or modulation of chromatin state. There is a lack of direct evidence indicating that PDK2-AS1 is a disease-related biomolecule or a validated therapeutic target, and no literature directly implicates it in cancer or other specific indications. Most available data on antisense RNAs discuss general regulatory mechanisms rather than specific functions for PDK2-AS1. Note: - There is no validated evidence that PDK2-AS1 itself functions as a protein, enzyme, receptor, or direct drug target. - The query may reflect a confusion between PDK2 (an enzyme and bona fide cancer-related target) and PDK2-AS1, its antisense RNA, which is not currently recognized as a therapeutic target or disease biomarker. - Marking is_incorrect: true is warranted due to the gene's status as a non-target lncRNA rather than a protein-coding, actionable molecular target.

Other names

PDK2-AS1PDK2 antisense RNA 1

Not therapeutically targeted; general mechanisms for antisense RNAs include modulation of mRNA stability, transcriptional interference, and chromatin modification